Science Explorer Interactive view Map
Research facility · Lille · ??

Médicaments et Molécules pour Agir sur les Systèmes Vivants

Research works
12
▲ 222% vs 2013–17
Citations
258
21.1 per fractional work
Top-10% rate
17.6%
record average 16.5%
Open access
79%
world 28%

Not ranked overall: Médicaments et Molécules pour Agir sur les Systèmes Vivants is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.79× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.74× its world share, 0 worksImmunology and Micro…Neuroscience: 0.34× its world share, 0 worksNeuroscienceChemistry: 3.70× its world share, 0 worksChemistryComputer Science: 0.49× its world share, 0 worksComputer ScienceEngineering: 0.24× its world share, 0 worksEngineeringEnvironmental Science: 1.44× its world share, 0 worksEnvironmental ScienceMedicine: 1.92× its world share, 2 worksMedicinePsychology: 0.18× its world share, 0 worksPsychologyworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.8×. Every wedge is a field page.

Which research topics does Médicaments et Molécules pour Agir sur les Systèmes Vivants publish most on?

By volume in 2022–2025: Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria, Pneumocystis jirovecii pneumonia detection and treatment and Biochemical and Molecular Research.

  1. 1 Tuberculosis Research and Epidemiology Infectious Diseases 0 works
  2. 2 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  3. 3 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works
  4. 4 Biochemical and Molecular Research Molecular Biology 0 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  6. 6 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  7. 7 Microbial Natural Products and Biosynthesis Pharmacology 0 works
  8. 8 Mycobacterium research and diagnosis Epidemiology 0 works
  9. 9 Cancer therapeutics and mechanisms Molecular Biology 0 works
  10. 10 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.6%not open21.4%

World: 28% of research is openly available.

with international co-authors38.2%domestic only61.8%

World: 19% is written across borders.

How has Médicaments et Molécules pour Agir sur les Systèmes Vivants's research output changed?

Output in 2018–2022 was 222% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lille

All research institutions in Lille

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.